Semaglutide for the treatment of obesity

AM Chao, JS Tronieri, A Amaro, TA Wadden - Trends in cardiovascular …, 2023 - Elsevier
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …
被引用次数：127 相关文章

Semaglutide for the treatment of obesity

AM Chao, JS Tronieri, A Amaro, TA Wadden - Trends in Cardiovascular …, 2023 - Elsevier
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …

Semaglutide for the treatment of obesity

AM Chao, JS Tronieri, A Amaro… - Trends in …, 2023 - pure.johnshopkins.edu
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …

Semaglutide for the treatment of obesity.

AM Chao, JS Tronieri, A Amaro… - Trends in Cardiovascular …, 2021 - europepmc.org
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …
[HTML] nih.gov

[HTML][HTML] Semaglutide for the Treatment of Obesity

AM Chao, JS Tronieri, A Amaro… - Trends in cardiovascular …, 2023 - ncbi.nlm.nih.gov
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …

Semaglutide for the treatment of obesity

AM Chao, JS Tronieri, A Amaro… - Trends in …, 2023 - pubmed.ncbi.nlm.nih.gov
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …

Semaglutide for the treatment of obesity.

AM Chao, JS Tronieri, A Amaro… - Trends in Cardiovascular …, 2021 - europepmc.org
Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the
US Food and Drug Administration for chronic weight management. This paper reviews data …